KMID : 1104820220100020074
|
|
Journal of Digestive Cancer Research 2022 Volume.10 No. 2 p.74 ~ p.81
|
|
Recent Update on the Treatment of Colorectal Peritoneal Metastasis: A Surgical Perspective
|
|
Cho Hye-Jung
Kim Woo-Ram
|
|
Abstract
|
|
|
Colorectal peritoneal metastasis has been an incurable disease for centuries. However, since the new millennium, recent advancements in therapies are achieved with modern chemotherapeutic agents, target agents, and immune checkpoint blockade introduction. Modern chemotherapies, from a nearly nonexistent median survival if untreated, have raised the duration to 16 months with target agents. Experts have once again surpassed its limit by introducing intraperitoneal chemotherapy and cytoreductive surgery (CRS). Numerous clinical trials regarding CRS and hyperthermic intraperitoneal chemotherapy have now opened new doors in peritoneal carcinomatosis treatment, even securing complete remission. In addition, up-to-date modalities, such as pressurized intraperitoneal aerosol chemotherapy and immunotherapies, showed promising results at an early stage.
|
|
KEYWORD
|
|
Colorectal neoplasm, Peritoneal neoplasms, Cytoreductive surgery, Hyperthermic, Intraperitoneal chemotherapy
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|